Article
Cerebral Microbleeds as a Biomarker in Alzheimer’S Disease? A Review in The Field
7 Dec 2015
Abstract excerpt
Cerebral microbleeds (CMBs) are a marker of small vessel disease, increasingly recognized as being of importance in the Alzheimer's disease (AD) process. CMBs influence in AD, and its longitudinal impact on disease progression is however still unknown. CMBs show several associations with AD across studies, are associated with decreased cerebrospinal fluid amyloid levels and are related with the ApoE ϵ4 allele, as...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
